Boehringer Ingelheim Vetmedica GmbH

Company Premium

Boehringer Ingelheim Animal Health Business Unit

Boehringer Ingelheim is the second largest animal health business in the world, with net sales of 4 billion euros in 2019 and presence in more than 150 markets.

As the lives of animals and humans are intertwined, across the globe, our 10,000 employees are dedicated to enhancing the well-being of both – through science and innovation, as well as with their commitment and passion.

Respect for animals, people and the environment is at the heart of what we do. We develop medicines, services and innovative digital technologies to protect animals from disease and pain. We support our customers in taking care of the health of their animals and protect our communities against life- and society- threatening diseases.

For more information visit: www.boehringer-ingelheim.com/animal-health/overview

 

The microbiome and viral infections

07-Nov-2017
This article relates different microbiome profiles to greater or lesser severity in clinical signs, lesions and viral load in a co-infection with PRRS and PCV2 viruses, opening a window of opportunity.

Clinical case: Bowel Oedema

This case study describes an outbreak in a commercial unit which proved difficult to stop without vaccine. Since 2014 an increasing number of cases of this disease have been reported in Europe though it remains unclear why it has reappeared.

Welcome to 333

Connect, share, and interact with the largest community of professionals in the swine industry.

Celebrating 153720Users on 333!

Sign upAlready a member?
Recommended accounts
Zhou  Lydia

Zhou Lydia

Other - China
DAVI  LIOU

DAVI LIOU

Other - China
Boehringer Ingelheim Vetmedica GmbH
Company - Germany
Lallemand

Lallemand

Company - France
pig333

pig333

Company - Spain